Abstract
Obesity is an important health problem because it is associated with diseases such as type 2 diabetes, hypertension, and hyperlipidemia in metabolic syndrome. The detail molecular mechanisms that underlie obesity have not been fully elucidated, and its therapeutic approach is of general interest. There is increasing evidence that obesity is under control of several factors in the brain and a number of studies have revealed that the brain functions that regulate energy balance play a central role in the development of obesity. Several orexigenic and anorexigenic neuropeptides in the brain are involved in obesity, although their relative contributions are different. The histamine-containing neurons and its receptors are distributed throughout the brain. The results of pharmacological studies revealed that neuronal histamine and its receptors are involved in the regulation of obesity in rodents and humans. In this review, we describe the neuronal histamine and its receptor as a pharmacological molecular target for obesity.
Keywords: Histamine, obesity, food intake, histamine H1 receptor, histamine H3 receptor
Current Molecular Pharmacology
Title: Molecular Mechanisms of Neuronal Histamine and its Receptors in Obesity
Volume: 2
Author(s): Takayuki Masaki and Hironobu Yoshimatsu
Affiliation:
Keywords: Histamine, obesity, food intake, histamine H1 receptor, histamine H3 receptor
Abstract: Obesity is an important health problem because it is associated with diseases such as type 2 diabetes, hypertension, and hyperlipidemia in metabolic syndrome. The detail molecular mechanisms that underlie obesity have not been fully elucidated, and its therapeutic approach is of general interest. There is increasing evidence that obesity is under control of several factors in the brain and a number of studies have revealed that the brain functions that regulate energy balance play a central role in the development of obesity. Several orexigenic and anorexigenic neuropeptides in the brain are involved in obesity, although their relative contributions are different. The histamine-containing neurons and its receptors are distributed throughout the brain. The results of pharmacological studies revealed that neuronal histamine and its receptors are involved in the regulation of obesity in rodents and humans. In this review, we describe the neuronal histamine and its receptor as a pharmacological molecular target for obesity.
Export Options
About this article
Cite this article as:
Masaki Takayuki and Yoshimatsu Hironobu, Molecular Mechanisms of Neuronal Histamine and its Receptors in Obesity, Current Molecular Pharmacology 2009; 2 (3) . https://dx.doi.org/10.2174/1874467210902030249
DOI https://dx.doi.org/10.2174/1874467210902030249 |
Print ISSN 1874-4672 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4702 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Controversial Issues of Abortion License According to Religious and Jurisprudential Laws in Iran: A Systematic Review
Current Women`s Health Reviews Fibrosis as a Therapeutic Target Post-Myocardial Infarction
Current Pharmaceutical Design Educating Scientists in Translational and Entrepreneurial Medicine: Unmet Needs and Challenges
Technology Transfer and Entrepreneurship (Discontinued) Effects of Mindfulness on Diabetes Mellitus: Rationale and Overview
Current Diabetes Reviews Nature and Nurture in the Early-Life Origins of Metabolic Syndrome
Current Pharmaceutical Biotechnology Expeditious and Green Synthesis of 2,3-Dihydroquinazolin-4(1H)-ones Catalyzed by Nano-MgO
Letters in Organic Chemistry Atherogenesis in White Coat Hypertension
Current Hypertension Reviews Sedation in PACU: Indications, Monitoring, Complications
Current Drug Targets Polyphenols-Rich Natural Products for Treatment of Diabetes
Current Medicinal Chemistry Renin-Angiotensin Antagonists: Therapeutic Effects Beyond Blood Pressure Control?
Current Pharmaceutical Design Pleiotropic Effects of Statins in Atherosclerotic Disease: Focus on the Antioxidant Activity of Atorvastatin
Current Topics in Medicinal Chemistry CD36 as a Therapeutic Target for Endothelial Dysfunction in Stroke
Current Pharmaceutical Design Targeting Conserved Pathways: Mitochondrial Dysfunction and Beyond
Current Neurovascular Research Cytochrome P450 4A Fatty Acid Omega Hydroxylases
Current Drug Metabolism Study on the Effect of HPMC on Compression Coated Floating Pulsatile Delivery of Bisoprolol
Current Drug Therapy Molecular Targets of Diabetic Vascular Complications and Potential New Drugs
Current Drug Targets Pharmacokinetic and Pharmacodynamic Variability: A Daunting Challenge in Drug Therapy
Current Drug Metabolism Perivascular Adipose Tissue as an Endocrine Organ: The Role of Statins
Current Pharmaceutical Design Cardiovascular and Renovascular Implications of COX-2 Inhibition
Current Pharmaceutical Design Human Ghrelin: A Gastric Hormone with Cardiovascular Properties
Current Pharmaceutical Design